Skip to main content

Table 7 Multidrug-resistant bacteria ESBL and MRSA in NICU

From: Low incidence of multidrug-resistant bacteria and nosocomial infection due to a preventive multimodal nosocomial infection control: a 10-year single centre prospective cohort study in neurocritical care

Parameter

Unit

Total population N=3464

NI group N=198

Control group N=3266

p value

Multidrug-resistant

pts

116(3.3%)

12(6.1%)

104(3.2%)

0.029

ESBL

pts

67(1.9%)

6(3.0%)

61(1.9%)

0.566

 On admission

pts

36(1.0%)

4(2.0%)

32(1.0%)

0.249

  Nose

pts

11(0.3%)

1(0.5%)

10(0.3%)

0.986

  Throat

pts

21(0.6%)

4(2.0%)

17(0.5%)

0.051

  Trachea

pts

15(0.4%)

1(0.5%)

14(0.4%)

0.725

  Urine

pts

19(0.5%)

0(0.0%)

19(0.6%)

0.106

  Rectum

pts

31(0.9%)

3(1.5%)

28(0.9%)

0.848

  Brain

pts

2(0.1%)

1(0.5%)

1(0.0%)

0.039

  Others

pts

5(0.1%)

1(0.5%)

4(0.1%)

0.369

MRSA

pts

52(1.5%)

7(3.5%)

45(1.4%)

0.320

 On admission

pts

22(0.6%)

0(0.0%)

22(0.7%)

0.015

  Nose

pts

27(0.8%)

4(2.0%)

23(0.7%)

0.766

  Throat

pts

11(0.3%)

1(0.5%)

10(0.3%)

0.632

  Trachea

pts

14(0.4%)

2(1.0%)

12(0.4%)

0.916

  Brain

pts

5(0.1%)

1(0.5%)

4(0.1%)

0.652

  Haemoculture

pts

1(0.0%)

0(0.0%)

1(0.0%)

0.690

  Others

pts

5(0.1%)

0(0.0%)

5(0.2%)

0.354

  1. NICU neurointensive care unit, ESBL Extended spectrum beta-lactamase, MRSA Methicillin-resistant Staphylococcus aureus